MESSAGE FROM THE CHIEF
Welcome to the Division of Immunology and Rheumatology. We strive to provide outstanding care for patients with immune-mediated and rheumatic disease, including rheumatoid arthritis, systemic lupus erythematosus,ankylosing spondylitis, psoriatic arthritis, systemic sclerosis, poly- and dermatomyositis, vasculitis, gout and osteoarthritis. We bring the benefit of pioneering research to our patients and educate the next generation of specialists in the diagnosis, treatment and exploration of autoimmune disease.
To understand and treat immune-mediated and rheumatic diseases pursuing excellence in research, patient care, and education.
- To advance paradigm-shifting biomedical research into the causes and treatment of human disease
- To provide transformative care for the prevention, diagnosis and treatment of immune-mediated and rheumatic diseases
- To educate physician-investigators
- To promote diversity and inclusion
SUPERIOR TRAINING AND EDUCATION
The commitment of Stanford has enabled the recruitment of new faculty members to our Division in the past five years, construction of new facilities (the Center for Clinical Sciences Research, (CCSR), and administrative reorganization to provide a critical mass and optimal environment for collaborative research and training within the field of adult rheumatology.
The goal of our Division is to leverage these institutional resources to perform leading research, provide superb clinical care, and prepare highly qualified candidates for careers as academic physician-scientists in the field of rheumatology.
Friday, February 11, 2022
Dear Division Member and Colleagues,
I write with a heavy heart that Sam Strober passed away this morning. He was peaceful and surrounded by family at his home in Portola Valley, with the foot of his bed looking out over the surrounding hills.
Sam was a giant in the field of transplant tolerance, and pioneered methods for the induction of tolerance through combined organ and hematopoietic cell transplants. His discoveries established strategies to eliminate use of immunosuppressive drugs in organ transplant patients. He also develop methods for the use of local tumor radiation to enhance effective anti-tumor responses.
Sam was a long-standing active and engaged member of our Division who always had sage insights and guidance. He served as the Chief of our Division for over a decade.
There will be a formal celebration of his life in conjunction with the Department of Medicine and his family in the coming months.
2021 Annual Report - Department of Medicine: Dr. Lorinda Chung was featured in the Department of Medicine's 2021 Annual Report: "Systemic Sclerosis: A Rare Disease That Requires Several Specialists"
Recurring Weekly Events
- Fri 10:45am weekly Fellows Didactic Conference
- Fri 12noon weekly Grand Rounds
- Fri 1pm weekly Journal Club
- Division Faculty Meeting: February 11, 2022
- Division Faculty Meeting: March 11, 2022
- Clinical Faculty Discussion: March 11, 2022
- Division Faculty Meeting: April 8, 2022
- Division Faculty Meeting: May 13, 2022
- Clinical Faculty Discussion: May 13, 2022
- Division Faculty Meeting: June 10, 2022
- Division Faculty Meeting: July 8, 2022
- Clinical Faculty Discussion: July 8, 2022
- Division Faculty Meeting: August 12, 2022